Figure legends :
Figure (1) : Relation between TLR3.rs3775290 (c.1377C/T)
genotype and total HCV-specific CMI response among total subjects (A),
seronegative, aviraemic subjects (B), seronegativeviraemic subjects (C), spontaneously resolved subjects (D),and chronic HCV patients (E). Data are shown as
scatter plots. For each subject, the total cumulative number of
HCV-specific IFN-γ spot-forming cells (SFC) per 106PBMCs is shown for responding and non-responding healthcare workers
(HCWs) and patients. Error bars represent the SEM.
Figure (2) : Relationship betweenTLR9.rs5743836 (-1237T→C)
genotype and total HCV-specific CMI response among the total subjects
(A), seronegative aviraemic subjects (B), seronegativeviraemic subjects (C), spontaneously resolved subjects (D),and chronic HCV patients (E). Data are shown as
scatter plots. For each subject, the total cumulative number of
HCV-specific IFN-γ spot-forming cells (SFC) per 106PBMCs is shown for responding and non-responding healthcare workers
(HCWs) and patients. Error bars represent the SEM.
Figure (3): Relationship between TLR9.rs352140 (G2848A) genotype
and total HCV-specific CMI response among the total subjects (A)
seronegative, aviraemic subjects (B) seronegative,viraemic subjects (C) spontaneously resolved subjects (D) andchronic HCV patients (E). Data are shown as scatter plots. For
each subject, the total cumulative number of HCV-specific IFN-γ
spot-forming cells (SFC) per 106 PBMCs is shown for
responding and non-responding HCWs and patients. Error bars represent
the SEM.